CLINICAL NEWS
submitting an abstract to the ASH Meeting
on Hematologic malignancies won’t hurt your
chance of getting the same abstract accepted to
the annual meeting! Attendees will have ample
opportunity to interact with their colleagues
who present abstracts or posters – that isn’t
always possible at a larger meeting – so we
really want attendees to take advantage of this
small-meeting format. ●
Important Dates & Reminders
The ASH Meeting on Hematologic
Malignancies will also showcase peerreviewed clinical research in core
malignancies. All submitted abstracts will
be considered for presentation as posters,
while authors of the top abstracts will be
invited to present their research at an oral
session.
Remember, all abstracts submitted to this
meeting will also be eligible for submission
to the 2015 ASH Annual Meeting.
Important dates to keep in mind:
• Advance Online Registration Opens: Mar 25
• Abstract Submission Deadline: July 1
• Advance Online Registration Closes:
Sept 7
PROPHYLAXIS STARTING WITH
50 IU/kg EVERY 4 DAYS
• Regimen may be adjusted based on patient response in the range of 25 to 65 IU/kg at 3- to 5-day intervals
• More frequent or higher doses (up to 80 IU/kg) may be required in children <6 years of age
• After administering ELOCTATE, the one-stage clotting assay or c